Dynamic measurement of key variables for the Ningbo Schizophrenia Cohort follow-up
Type of information | Variables | Baseline | Follow-up |
Sociodemographics | Sex, age, ethnicity, occupation, education years, marital status, economic status, type of health insurance and residence | * | |
Pre-existing mental disorders | Diagnosis of other mental disorders | * | |
Previous forms of psychiatric treatment | * | ||
Risk factors for schizophrenia | Familial psychiatry history | * | |
Childhood trauma | * | ||
Socioeconomic status | * | ||
Season of birth | * | ||
Urbanicity | * | ||
Green spaces | * | ||
Air pollutants | * | ||
Body mass index | * | * | |
Lifestyle factors | Smoking | * | |
Alcohol consumption | * | ||
Physical activity | * | ||
Psychological status | Suicidal intent | * | |
History of suicide attempts | * | ||
Positive and Negative Syndrome Scale | * | ||
Brief Psychiatric Rating Scale | * | ||
Duration of untreated psychosis | * | ||
Symptoms and severity | Age of first psychiatric hospitalisation | * | |
Mode of onset | * | ||
Clinical Global Impression | * | ||
Global Assessment Scale | * | ||
Social Disability Screening Schedule | * | * | |
Number of psychiatric outpatient visits | * | * | |
Risk assessment | * | * | |
Number of psychiatric admissions and length of stay | * | * | |
Date of last psychiatric discharge | * | * | |
Nurses’ Observation Scale for Inpatient Evaluation | *† | *† | |
Psychotropic medication | Time to first antipsychotic medication | * | * |
Duration of medication | * | ||
Drug name | * | ||
Dose | * | ||
Chlorpromazine equivalent | * | ||
Defined daily dose51 | * | ||
Adherence to medication | * | ||
Adverse drug reactions | * | ||
Death | Cause and date of death | * | |
Medical condition | Other comorbidities (eg, cardiovascular disease, gastrointestinal system disease, endocrine system disease and neurological system disease) | * | * |
Medication | * | * | |
Ancillary tests | Laboratory tests | * | * |
Imaging studies (eg, CT and MRI) | * | * | |
Health economics | Outpatient costs | * | * |
Prescription costs | * | * | |
Hospitalisation costs | * | *† |
*Variables were collected at this stage.
†Variables were measured at hospitalisation.